Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

Similar articles for PubMed (Select 21266841)

1.

Mutants of plant genes for developing cancer vaccines.

Massa S, Paolini F, Spanò L, Franconi R, Venuti A.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:147-55. Epub 2011 Jan 1.

2.

An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.

Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, Kaufmann AM.

Vaccine. 2006 Apr 5;24(15):2880-93. Epub 2006 Jan 19.

PMID:
16472545
3.

Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein.

Smahel M, Poláková I, Pokorná D, Ludvíková V, Dusková M, Vlasák J.

Int J Oncol. 2008 Jul;33(1):93-101.

PMID:
18575754
4.

[Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].

Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):584-91. Chinese.

5.

Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.

Pokorná D, Macková J, Dusková M, Rittich S, Ludvíková V, Smahel M.

J Gene Med. 2005 Jun;7(6):696-707.

PMID:
15712328
6.

Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.

Báez-Astúa A, Herráez-Hernández E, Garbi N, Pasolli HA, Juárez V, Zur Hausen H, Cid-Arregui A.

J Virol. 2005 Oct;79(20):12807-17.

7.

Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein.

Massa S, Simeone P, Muller A, Benvenuto E, Venuti A, Franconi R.

Hum Gene Ther. 2008 Apr;19(4):354-64. doi: 10.1089/hum.2007.122.

PMID:
18439124
8.

Exploiting the plant secretory pathway to improve the anticancer activity of a plant-derived HPV16 E7 vaccine.

Franconi R, Massa S, Illiano E, Mullar A, Cirilli A, Accardi L, Di Bonito P, Giorgi C, Venuti A.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):187-97.

PMID:
16569357
9.

Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines.

Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.

J Virol. 2009 Jul;83(13):6779-89. doi: 10.1128/JVI.02443-08. Epub 2009 Apr 22.

11.

A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers.

Radaelli A, De Giuli Morghen C, Zanotto C, Pacchioni S, Bissa M, Franconi R, Massa S, Paolini F, Muller A, Venuti A.

Virus Res. 2012 Dec;170(1-2):44-52. doi: 10.1016/j.virusres.2012.08.007. Epub 2012 Aug 19.

PMID:
22951311
12.

Induction of CD4-independent E7-specific CD8+ memory response by heat shock fusion protein.

Liu H, Wu BH, Rowse GJ, Emtage PC.

Clin Vaccine Immunol. 2007 Aug;14(8):1013-23. Epub 2007 Jun 27.

13.
15.

Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.

Seo SH, Jin HT, Park SH, Youn JI, Sung YC.

Vaccine. 2009 Sep 25;27(42):5906-12. doi: 10.1016/j.vaccine.2009.07.033. Epub 2009 Aug 3.

PMID:
19651174
16.

Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice.

Gomez-Gutierrez JG, Elpek KG, Montes de Oca-Luna R, Shirwan H, Sam Zhou H, McMasters KM.

Cancer Immunol Immunother. 2007 Jul;56(7):997-1007. Epub 2006 Dec 5.

PMID:
17146630
17.

Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells.

Di Bonito P, Grasso F, Mangino G, Massa S, Illiano E, Franconi R, Fanales-Belasio E, Falchi M, Affabris E, Giorgi C.

Int J Immunopathol Pharmacol. 2009 Oct-Dec;22(4):967-78.

PMID:
20074460
19.

Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.

Sewell DA, Shahabi V, Gunn GR 3rd, Pan ZK, Dominiecki ME, Paterson Y.

Cancer Res. 2004 Dec 15;64(24):8821-5.

20.

Oral immunization with a Lactobacillus casei vaccine expressing human papillomavirus (HPV) type 16 E7 is an effective strategy to induce mucosal cytotoxic lymphocytes against HPV16 E7.

Adachi K, Kawana K, Yokoyama T, Fujii T, Tomio A, Miura S, Tomio K, Kojima S, Oda K, Sewaki T, Yasugi T, Kozuma S, Taketani Y.

Vaccine. 2010 Apr 1;28(16):2810-7. doi: 10.1016/j.vaccine.2010.02.005. Epub 2010 Feb 17.

PMID:
20170766
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk